Neurovascular Devices – Market Insights – Latin America

While the COVID-19 pandemic has had a limited negative impact on the Latin American neurovascular device market, the market will grow modestly through 2031, driven by the adoption of innovative devices backed by favorable clinical data and rising demand for neurovascular procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in Latin America from 2019 through 2031.

The COVID-19 pandemic had a relatively limited impact on the Latin American neurovascular device market in 2020.

How will the impact of the COVID-19 pandemic vary across different neurovascular device segments?

How quickly will recovery occur?

The results of the HEAT trial demonstrated the superiority of hydrogel-coated embolization coils in comparison to bare platinum coils.

How dramatically will these results impact the use of coated and bare platinum coils?

What role will cost play in device uptake?

Clinical data supporting the effectiveness of neurovascular thrombectomy procedures for the treatment of ischemic stroke will fuel this market segment.

How much growth is expected in this market segment in the Latin American region?

What impact will device cost have on the uptake of thrombectomy devices?

Table of contents